Companies / Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

Nasdaq: ODTXCIK 1882782BOSTON, MA

Ownership

48.1M shares outstanding · as of Aug 3, 2026
0.63%Insiders
Ownership
Insiders0.63%301,842
10%+ / strategic7.68%3,690,146
Institutions0.50%240,679
Public float91.19%43,825,860

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Tpg Gp a, LLC10% owner
7.68%3,690,146
Leiden Jeffrey MDirector
0.63%301,842
Coulter James G10% owner
——
Smith Ian FDirector
——
Walbert Timothy PDirector
——
Winkelried Jon10% owner
——

Institutional holders 1

View all →
HolderValue% of shares
BlackRock, Inc.$4.50M0.50%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 11, 2026Tpg Gp a, LLC
10% owner
BuyCommon Stock$25.00M+1.4M
+60.35%
3,690,146
7.68% of shares
high
May 8, 2026Leiden Jeffrey M
Director
BuyCommon Stock$100.0K+5K
+1.89%
270,198
0.56% of shares
medium
May 11, 2026Tpg Gp a, LLC
10% owner
OtherCommon Stock$42.3K-2K
-0.56%
420,760
0.88% of shares
low
May 11, 2026Leiden Jeffrey M
Director
OtherCommon Stock$306-17
-0.05%
31,644
0.07% of shares
low
May 7, 2026Walbert Timothy P
Director
GrantStock Option (Right to Buy)—+27K
27,393
0.06% of shares
low
May 11, 2026Leiden Jeffrey M
Director
ExerciseSeries D Warrants (Right to Buy)—-29K
-100.00%
0
0.00% of shares
low
May 7, 2026Leiden Jeffrey M
Director
GrantStock Option (Right to Buy)—+626K
626,220
1.30% of shares
low
May 11, 2026Leiden Jeffrey M
Director
OtherSeries D Convertible Preferred Stock—-96K
-100.00%
0
0.00% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ODTXCommon StockEquity67613T104BBG0135WDLY8